Vaxart Inc.

NASDAQ: VXRT · Real-Time Price · USD
0.49
-0.04 (-7.98%)
At close: Jun 27, 2025, 3:59 PM

Vaxart Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
47.4M 28.7M 16.76M 12.27M 7.23M 5.33M 2.1M 1.66M 300K 107K 159K 359K 471K 892K 1.17M 1.24M 1.65M
Cost of Revenue
18.58M 19.68M 19.78M 20.98M 4.63M 3.53M 3.29M 2.92M 2.58M 20.78M 35.34M 46.93M 56.88M 48.75M 41.81M 34.02M 28.39M
Gross Profit
7.94M 9.02M -3.02M -8.71M 2.6M 1.8M -1.19M -1.26M -2.28M -20.67M -35.19M -46.57M -56.41M -47.86M -40.64M -32.78M -26.74M
Operating Income
-42.22M -66.29M -71.7M -75.05M -81.84M -83.35M -97.58M -109.19M -115.38M -114.59M -107.66M -95.49M -82.02M -72.75M -61.9M -52.24M -44.99M
Interest Income
2.48M 2.54M 2.52M 2.22M 2.51M 2.65M 2.67M 2.41M 1.85M 1.25M 673K 241K 107K 81K 64K 43K 43K
Pretax Income
-57.81M -66.69M -72.08M -75.38M -81.47M -82.2M -88.91M -100.84M -107.72M -107.69M -104.53M -92.8M -79.47M -70.36M -63.45M -53.94M -46.81M
Net Income
-58.12M -66.95M -72.34M -75.66M -81.74M -82.47M -89.01M -100.92M -107.8M -107.76M -104.6M -92.88M -79.56M -70.47M -63.57M -54.07M -46.93M
Selling & General & Admin
18.61M 19.68M 19.9M 20.48M 20.9M 21.38M 23.59M 25.63M 29.35M 29.39M 28.69M 26.77M 22.6M 21.89M 21.26M 20.41M 19.16M
Research & Development
85.94M 74.21M 66.26M 66.2M 67.53M 68.14M 73.9M 81.36M 82.47M 81.05M 76.13M 66.07M 56.88M 48.75M 41.81M 34.02M 28.39M
Other Expenses
n/a -1K -4K -59K -60K -456K -453K -398K -397K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
104.55M 93.89M 86.16M 85.02M 86.78M 87.47M 95.44M 106.59M 111.43M 110.44M 104.82M 92.84M 79.48M 70.64M 63.07M 54.43M 47.55M
Interest Expense
1.17M 2.97M 2.92M 2.5M 2.07M 1.45M 890K 1.01M 1.14M 1.3M 1.33M 1.34M 1.35M 1.48M 1.61M 1.74M 1.85M
Selling & Marketing Expenses
n/a -1.1M -2.3M -2.3M -2.3M -1.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
68.74M 94.99M 88.46M 87.32M 89.08M 88.67M 95.44M 106.59M 111.43M 110.44M 104.82M 92.84M 79.48M 70.64M 63.07M 54.43M 47.55M
Income Tax Expense
310K 260K 258K 279K 277K 261K 103K 80K 76K 67K 69K 74K 89K 107K 122K 127K 123K
Shares Outstanding (Basic)
227.92M 227.77M 2.27B 1.85B 1.69B 1.53B 1.52B 1.4B 135.21M 1.33B 1.27B 1.26B 1.26B 1.25B 1.24B 1.21B 1.15B
Shares Outstanding (Diluted)
227.92M 227.77M 2.27B 1.85B 1.69B 1.53B 1.52B 1.4B 135.21M 1.33B 1.27B 1.26B 1.26B 1.25B 1.24B 1.21B 1.15B
EPS (Basic)
-0.09 -0.04 -0.04 -0.04 -0.05 -0.23 -0.23 -0.25 -0.25 -0.08 -0.08 -0.07 -0.06 -0.06 -0.05 -0.05 -0.05
EPS (Diluted)
-0.09 -0.04 -0.04 -0.04 -0.05 -0.23 -0.23 -0.25 -0.25 -0.08 -0.08 -0.07 -0.06 -0.06 -0.05 -0.05 -0.05
EBITDA
-35.02M -56.92M -63.39M -67.02M -74.19M -75.17M -82.66M -94.85M -101.94M -103.1M -100.16M -88.6M -75.49M -66.45M -59.27M -49.82M -42.49M
EBIT
-40.15M -63.72M -69.16M -72.88M -79.39M -80.76M -88.02M -99.83M -106.58M -106.39M -103.2M -91.46M -78.12M -68.88M -61.84M -52.2M -44.96M
Depreciation & Amortization
6.67M 7.77M 6.74M 5.71M 4.63M 5.59M 5.36M 4.98M 4.64M 3.29M 3.04M 2.86M 2.63M 2.43M 2.57M 2.58M 2.64M